2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,739

Contemporary Definitions and Classification of the Cardiomyopathies

Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424

The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction

Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O. P., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,308

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244

ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities

Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546

Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,245

Hypertrophic Cardiomyopathy: A Systematic Review

Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,213

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116

Sudden Deaths in Young Competitive Athletes

Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,099

Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement From the American Heart Association

Balady, G. J., Arena, R., Sietsema, K., Myers, J., Coke, L., Fletcher, G. F., Forman, D., Franklin, B., Guazzi, M., Gulati, M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181e52e69 · Cited by 1,964

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189742 · Cited by 1,772

Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles

Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,398

Sudden Death in Young Athletes

Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394

Does sports activity enhance the risk of sudden death in adolescents and young adults?

Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.03.002 · Cited by 1,311

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259

Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,128

Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.106.644682 · Cited by 1,127

ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS

Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,082

The Genetic Basis for Cardiomyopathy

Seidman, J. G., & Seidman, C. E. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,050

The Management of Hypertrophic Cardiomyopathy

Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,026

High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

Spada, M., Pagliardini, S., Yasuda, M., Tükel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., & Desnick, R. J. (2006) · The American Journal of Human Genetics · doi:10.1086/504601 · Cited by 1,007

Screening for Hypertrophic Cardiomyopathy in Young Athletes

Corrado, D., Basso, C., Schiavon, M., & Thiene, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390602 · Cited by 997

Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology

Pelliccia, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi325 · Cited by 983

Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

Maceira, A. M., Joshi, J., Prasad, S. K., Moon, J., Perugini, E., Harding, I., Sheppard, M. N., Poole-Wilson, P. A., Hawkins, P. N., & Pennell, D. J. (2005) · Circulation · doi:10.1161/01.cir.0000152819.97857.9d · Cited by 982

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients

Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976

Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy

Watkins, H. C., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 935

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J. C., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 822

Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy

O’Hanlon, R., Grasso, A. E., Roughton, M., Moon, J., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D. K., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 816

Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy

Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 812

Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

Sigwart, U. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91267-3 · Cited by 797

Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy

Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 776

Hypertrophic Cardiomyopathy

Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 775

Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance

Moon, J., McKenna, W. J., McCrohon, J. A., Elliot, P. M., Smith, G. C., & Pennell, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00189-x · Cited by 767

Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients

D, E. B. M., Lambrew, C. T., Rockoff, S. D., Ross, J., & Morrow, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758

The Heart of Trained Athletes

Maron, B. J., & Pelliccia, A. (2006) · Circulation · doi:10.1161/circulationaha.106.613562 · Cited by 758

Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy

Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757

Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy

Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 754

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745

Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic Cardiomyopathy

Watkins, H. C., Rosenzweig, A., Hwang, D., Levi, T., McKenna, W. J., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 742

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

Pandit, B., Sárközy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A. P., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 715

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

Ho, C. Y., López, B., Coelho‐Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolı́m, P., Kwong, R. Y. K., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 697

Epidemiology of hypertrophic cardiomyopathy-Related death: Revisited in a large non-referral-based patient population

Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., & Cecchi, F. (2000) · Circulation · doi:10.1161/01.cir.102.8.858 · Cited by 677

Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey‐Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.105.583500 · Cited by 665

Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance

Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.071 · Cited by 662

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients

Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 653

Glycogen Storage Diseases Presenting as Hypertrophic Cardiomyopathy

Arad, M., Maron, B. J., Gorham, J., Johnson, W. H., Saul, J. P., Pérez‐Atayde, A. R., Spirito, P., Wright, G. B., Kanter, R. J., Seidman, C. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa033349 · Cited by 647

Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years

Kleemann, T., Becker, T., Doenges, K., Vater, M., Senges, J., Schneider, S., Saggau, W., Weisse, U., & Seidl, K. (2007) · Circulation · doi:10.1161/circulationaha.106.663807 · Cited by 633

Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

Choudhury, L., Mahrholdt, H., Wagner, A., Choi, K. M., Elliott, M. D., Klocke, F. J., Bonow, R. O., Judd, R. M., & Kim, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02602-5 · Cited by 627

Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features

McKenna, W. J., Deanfield, J. E., FARUQUI, A. M. A., England, D., Oakley, C. M., & Goodwin, J. F. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90535-x · Cited by 626

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy

Maron, B. J., Gottdiener, J. S., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90068-0 · Cited by 599

Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases

Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., Deal, B. J., Driscoll, D. J., Estes, N. A. M., Araújo, C. G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128363.85581.e1 · Cited by 591

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

Bruder, O., Wagner, A., Jensen, C. J., Schneider, S., Ong, P., Kispert, E.-M., Naßenstein, K., Schlosser, T. W., Sabin, G. V., Sechtem, U. P., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.007 · Cited by 590

Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy

Rickers, C., Wilke, N. M., Jerosch‐Herold, M., Casey, S. A., Panse, P. M., Panse, N., Weil, J., Zenovich, A. G., & Maron, B. J. (2005) · Circulation · doi:10.1161/circulationaha.104.507723 · Cited by 581

Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy

Maron, M. S., Finley, J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., & Maron, B. J. (2008) · Circulation · doi:10.1161/circulationaha.108.781401 · Cited by 566

The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the Literature

van den Hout, H. M. P., Hop, W. J. C., van Diggelen, O. P., Smeitink, J. A. M., Smit, G., Poll‐The, B. T., Bakker, H. D., Loonen, M. C. B., de Klerk, J. B. C., Reuser, A. J. J., et al. (2003) · PEDIATRICS · doi:10.1542/peds.112.2.332 · Cited by 554

Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort

Maron, B. J. (1999) · JAMA · doi:10.1001/jama.281.7.650 · Cited by 553

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy

Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541

Causes of sudden death in competitive athletes

Maron, B. J., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80283-2 · Cited by 536

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.001 · Cited by 529

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Mahon, N., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 517

Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance

Maron, M. S., Maron, B. J., Harrigan, C. J., Buros, J., Gibson, C. M., Olivotto, I., Biller, L. H., Lesser, J. R., Udelson, J. E., Manning, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.006 · Cited by 501

Global and Regional Myocardial Function Quantification by Two-Dimensional Strain

Serri, K., Réant, P., Lafitte, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.061 · Cited by 497

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study

Maron, B. J., Savage, D. D., Wolfson, J. K., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90604-4 · Cited by 494

Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Maron, B. J., Nishimura, R. A., McKenna, W. J., Rakowski, H., Josephson, M. E., & Kieval, R. S. (1999) · Circulation · doi:10.1161/01.cir.99.22.2927 · Cited by 490

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Cannon, R. O., Rosing, D. R., Maron, B. J., Leon, M. B., Bonow, R. O., Watson, R. M., & Epstein, S. E. (1985) · Circulation · doi:10.1161/01.cir.71.2.234 · Cited by 477

Long-term outcome in patients with apical hypertrophic cardiomyopathy

Eriksson, M. J., Sonnenberg, B., Woo, A., Rakowski, P., Parker, T. G., Wigle, E. D., & Rakowski, H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01778-8 · Cited by 476

Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children

Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J. E., Cox, G. F., Lurie, P. R., Orav, E. J., & Towbin, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.621185 · Cited by 472

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease Evidence for a disease specific abnormality of the myocardial interstitium

Moon, J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.017 · Cited by 469

Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease

Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0718 · Cited by 463

Hypertrophie cardiomyopathy: A discussion of nomenclature

Maron, B. J., & Epstein, S. E. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90160-7 · Cited by 442

Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

Moon, J., Fisher, N. G., McKenna, W. J., & Pennell, D. J. (2004) · Heart · doi:10.1136/hrt.2003.014969 · Cited by 439

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Tome, M., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 428

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

Driest, S. L. V., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 423

ACC/AHA/SCAI Practice Guidelines, February 21, 2006

(2006) · Circulation · doi:10.1161/circulationaha.106.173220 · Cited by 423

Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy

Ho, C. Y., Sweitzer, N. K., McDonough, B. A., Maron, B. J., Casey, S. A., Seidman, J. G., Seidman, C. E., & Solomon, S. D. (2002) · Circulation · doi:10.1161/01.cir.0000019070.70491.6d · Cited by 420

Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.854026 · Cited by 418

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy

Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410

Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults

Morita, H., Rehm, H. L., Menesses, A., McDonough, B. A., Roberts, A. E., Kucherlapati, R., Towbin, J. A., Seidman, J. G., & Seidman, C. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075463 · Cited by 404

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B., Casey, S. A., Gohman, T. E., Bongioanni, S., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01727-2 · Cited by 396

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.

Bonow, R. O., Rosing, D. R., Bacharach, S. L., Green, M. V., Kent, K. M., Lipson, L. C., Maron, B. J., Leon, M. B., & Epstein, S. E. (1981) · Circulation · doi:10.1161/01.cir.64.4.787 · Cited by 393

Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy

Bos, J. M., Towbin, J. A., & Ackerman, M. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.075 · Cited by 392

Cardiac Disease in Young Trained Athletes

Maron, B. J., Pelliccia, A., & Spirito, P. (1995) · Circulation · doi:10.1161/01.cir.91.5.1596 · Cited by 387

Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics

Alcalai, R., Seidman, J. G., & Seidman, C. E. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00965.x · Cited by 387

Sudden Death due to Troponin T Mutations

Moolman, J. C., Corfield, V. A., Posen, B., Ngumbela, K. C., Seidman, C. E., Brink, P. A., & Watkins, H. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00530-x · Cited by 387

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C. E., & Semsarian, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033886 · Cited by 385

Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy

Olivotto, I., Girolami, F., Ackerman, M. J., Nistri, S., Bos, J. M., Zachara, E., Ommen, S. R., Theis, J. L., Vaubel, R. A., Re, F., et al. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.630 · Cited by 380

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

Fananapazir, L., Epstein, N. D., Curiel, R., Panza, J. A., Tripodi, D., & McAreavey, D. (1994) · Circulation · doi:10.1161/01.cir.90.6.2731 · Cited by 380

Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial

Nishimura, R. A., Trusty, J. M., Hayes, D. L., Ilstrup, D. M., Larson, D. R., Hayes, S. N., Allison, T. G., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00473-1 · Cited by 376

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary

Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189741 · Cited by 366

Syncope and risk of sudden death in hypertrophic cardiomyopathy

Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798314 · Cited by 365

Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy.

Klues, H. G., Maron, B. J., Dollar, A. L., & Roberts, W. C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1651 · Cited by 361

Side effects of long-term amiodarone therapy.

Harris, L., McKenna, W. J., Rowland, E., Holt, D. W., Storey, G., & KRIKLER, D. M. (1983) · Circulation · doi:10.1161/01.cir.67.1.45 · Cited by 358

[Guidelines for the management of patients with atrial fibrillation. Executive summary].

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · PubMed · Cited by 356

Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy

Patel, R., Nagueh, S. F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H. A., Quiñones, M. A., Zoghbi, W. A., Entman, M. L., Roberts, R., et al. (2001) · Circulation · doi:10.1161/hc2801.094031 · Cited by 353

Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy

Faber, L., Seggewiß, H., & Gleichmann, U. (1998) · Circulation · doi:10.1161/01.cir.98.22.2415 · Cited by 346

Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy

Maron, B. J. (2009) · JAMA · doi:10.1001/jama.2009.371 · Cited by 343

Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography

Camici, P. G., Chiriatti, G., Lorenzoni, R., Bellina, R. C., Gistri, R., Italiani, G., Parodi, O., Salvadori, P. A., Nista, N., Papi, L., et al. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90869-b · Cited by 338

Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy

Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S. C., Ralph-Edwards, A. C., & Rakowski, H. (2005) · Circulation · doi:10.1161/01.cir.0000162460.36735.71 · Cited by 334

Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy

Sadoul, N., Prasad, K., Elliot, P. M., Bannerjee, S., Frenneaux, M. P., & McKenna, W. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.2987 · Cited by 331

Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy

Geske, J. B., Sorajja, P., Nishimura, R. A., & Ommen, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.698985 · Cited by 328

Evaluation of Patients With Severe Symptomatic Aortic Stenosis Who Do Not Undergo Aortic Valve Replacement: The Potential Role of Subjectively Overestimated Operative Risk

Bach, D. S., Siao, D., Girard, S. E., Duvernoy, C., McCallister, B. D., & Gualano, S. K. (2009) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.848259 · Cited by 327

Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient Population

Spirito, P., Chiarella, F., Carratino, L., Berisso, M. Z., Bellotti, P., & Vecchio, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903233201201 · Cited by 326

Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy

Jeanrenaud, X., Goy, J., & KAPPENBERGER, L. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)91961-7 · Cited by 324

Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies

Bourassa, M. G., Butnaru, A., Lespérance, J., & Tardif, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02768-7 · Cited by 323

Hypertrophic Obstructive Cardiomyopathy

Nishimura, R. A., & Holmes, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp030779 · Cited by 320

Recommendations for reducing radiation exposure in myocardial perfusion imaging

Cerqueira, M. D., Allman, K. C., Ficaro, E. P., et al. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9244-0 · Cited by 313

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy

Maron, B. J., Carney, K. P., Lever, H. M., Lewis, J. F., Barač, I., Casey, S. A., & Sherrid, M. V. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02976-5 · Cited by 309

Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis).

Brock, R. (1957) · PubMed · Cited by 309

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.025 · Cited by 307

The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy

Maron, M. S., Olivotto, I., Maron, B. J., Prasad, S. K., Cecchi, F., Udelson, J. E., & Camici, P. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.072 · Cited by 306

THE GENETIC BASIS FOR CARDIAC REMODELING

Ahmad, F., Seidman, J. G., & Seidman, C. E. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162132 · Cited by 305

Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Sorajja, P., Valeti, U. S., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R. (2008) · Circulation · doi:10.1161/circulationaha.107.738740 · Cited by 303

Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

Maron, B. J. (2010) · Circulation · doi:10.1161/circulationaha.109.878579 · Cited by 298

Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy

Sherrid, M. V., Gunsburg, D. Z., Moldenhauer, S., & Pearle, G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00830-5 · Cited by 297

Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population

Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296

Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults

Zou, Y., Song, L., Wang, Z., Ma, A., Liu, T., Gu, H., Lu, S., Peng-zhu, W., Zhang, †. Y., Shen, †. L., et al. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.05.009 · Cited by 296

Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited

Pelliccia, A., Zipes, D. P., & Maron, B. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.055 · Cited by 295

Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations

Girolami, F., Ho, C. Y., Semsarian, C., Baldi, M., Will, M. L., Baldini, K., Torricelli, F., Yeates, L., Cecchi, F., Ackerman, M. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.062 · Cited by 295

Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study

KAPPENBERGER, L. J., Linde, C. M., Daubert, C., McKenna, W. J., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 295

Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy

Maron, M. S., Appelbaum, E. A., Harrigan, C. J., Buros, J., Gibson, C. M., Hanna, C., Lesser, J. R., Udelson, J. E., Manning, W. J., & Maron, B. J. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.768119 · Cited by 295

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

Fananapazir, L., Cannon, R. O., Tripodi, D., & Panza, J. A. (1992) · Circulation · doi:10.1161/01.cir.85.6.2149 · Cited by 292

Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

Monserrat, L., Gimeno, J. R., Marín, F. R., Hermida‐Prieto, M., García‐Honrubia, A., Pérez, I., Fernández, X., de Nicolás, R., de la Morena, G., Payá, E., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.062 · Cited by 291

Surgical Treatment of Idiopathic Hypertrophic Subaortic Stenosis

Morrow, A. G., & Brockenbrough, E. C. (1961) · Annals of Surgery · doi:10.1097/00000658-196108000-00003 · Cited by 287

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Anan, R., Greve, G., Thierfelder, L., Watkins, H. C., McKenna, W. J., Solomon, S. D., Vecchio, C., Shono, H., Nakao, S., & Tanaka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116957 · Cited by 285

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

Frenneaux, M. P., Counihan, P. J., Caforio, A. L. P., Chikamori, T., & McKenna, W. J. (1990) · Circulation · doi:10.1161/01.cir.82.6.1995 · Cited by 282

Morning increase in platelet aggregability. Association with assumption of the upright posture.

Brezinski, D. A., Tofler, G. H., Muller, J. E., Pohjola‐Sintonen, S., Willich, S. N., Schafer, A. I., Czeisler, C. A., & Williams, G. H. (1988) · Circulation · doi:10.1161/01.cir.78.1.35 · Cited by 282

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article : A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines

Smith, S. J. (2006) · Journal of the American College of Cardiology · Cited by 280

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

Dilsizian, V., Bonow, R. O., Epstein, S. E., & Fananapazir, L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90193-5 · Cited by 276

Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for Hypertrophic Cardiomyopathy

Agarwal, S., Tuzcu, E. M., Desai, M. Y., Smedira, N. G., Lever, H. M., Lytle, B. W., & Kapadia, S. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.047 · Cited by 276

Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease

Nagueh, S. F., McFalls, J., Meyer, D., Hill, R., Zoghbi, W. A., Tam, J. W., Quiñones, M. A., Roberts, R., & Marian, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000084500.72232.8d · Cited by 275

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S. R., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14677 · Cited by 275

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy

Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

Epstein, S. E., & Rosing, D. R. (1981) · Circulation · doi:10.1161/01.cir.64.3.437 · Cited by 272

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

Bonow, R. O., Dilsizian, V., Rosing, D. R., et al. (1985) · Circulation · doi:10.1161/01.cir.72.4.853 · Cited by 272

Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy

Smedira, N. G., Lytle, B. W., Lever, H. M., Rajeswaran, J., Krishnaswamy, G., Kaple, R., Dolney, D., & Blackstone, E. H. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.063 · Cited by 271

The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks

Offit, K. (2004) · JAMA · doi:10.1001/jama.292.12.1469 · Cited by 270

Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic Cardiomyopathy

Chimenti, C., Pieroni, M., Morgante, E., Antuzzi, D., Russo, A., Russo, M. A., Maseri, A., & Frustaci, A. (2004) · Circulation · doi:10.1161/01.cir.0000139847.74101.03 · Cited by 269

Functional, angiographic and intracoronary doppler flow characteristics in symptomatic patients with myocardial bridging: Effect of short-term intravenous beta-blocker medication

Schwarz, E. R., Klues, H. G., Dahl, J. V., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00062-9 · Cited by 268

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome

Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.011 · Cited by 265

Natural History of Hypertrophic Cardiomyopathy

Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 265

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

O’Gara, P. T., Bonow, R. O., Maron, B. J., Damske, B. A., van Lingen, A., Bacharach, S. L., Larson, S. M., & Epstein, S. E. (1987) · Circulation · doi:10.1161/01.cir.76.6.1214 · Cited by 265

Myocardial Bridging in Children with Hypertrophic Cardiomyopathy — A Risk Factor for Sudden Death

Yetman, A. T., McCrindle, B. W., MacDonald, C., Freedom, R. M., & Gow, R. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391704 · Cited by 265

Meta-analysis: Noninvasive Coronary Angiography Using Computed Tomography Versus Magnetic Resonance Imaging

Schuetz, G. M., Zacharopoulou, N. M., Schlattmann, P., & Dewey, M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-3-201002020-00008 · Cited by 263

Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction.

Klues, H. G., Roberts, W. C., & Maron, B. J. (1991) · Circulation · doi:10.1161/01.cir.84.3.1188 · Cited by 262

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Fananapazir, L., Chang, A. C., Epstein, S. E., & McAreavey, D. (1992) · Circulation · doi:10.1161/01.cir.86.3.730 · Cited by 259

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

Elliot, P. M., Sharma, S., Varnava, A. M., Poloniecki, J. D., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257

Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)

Nistri, S., Olivotto, I., Betocchi, S., Losi, M. A., Valsecchi, G., Pinamonti, B., Conte, M. R., Casazza, F., Galderisi, M., Maron, B. J., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.05.013 · Cited by 257

STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE

D, E. B. M., Bloodwell, R. D., Goldberg, L. I., et al. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104236 · Cited by 257

Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis

Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255

The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

Maron, B. J., Maron, M. S., Wigle, E. D., & Braunwald, E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.069 · Cited by 255

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

Olivotto, I., Maron, B. J., Montereggi, A., Mazzuoli, F., Dolara, A., & Cecchi, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00094-7 · Cited by 254

Association Between Regional Ventricular Function and Myocardial Fibrosis in Hypertrophic Cardiomyopathy Assessed by Speckle Tracking Echocardiography and Delayed Hyperenhancement Magnetic Resonance Imaging

Popović, Z., Kwon, D. H., Mishra, M., Buakhamsri, A., Greenberg, N. L., Thamilarasan, M., Flamm, S. D., Thomas, J. D., Lever, H. M., & Desai, M. Y. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.09.011 · Cited by 252

Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Gistri, R., Lorenzoni, R., Chiriatti, G., Girolami, F., Torricelli, F., & Camici, P. G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.050 · Cited by 249

Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study

Deisenhofer, I., Kolb, C., Ndrepepa, G., et al. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00134.x · Cited by 248

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

Rosing, D. R., Kent, K. M., Maron, B. J., & Epstein, S. E. (1979) · Circulation · doi:10.1161/01.cir.60.6.1208 · Cited by 244

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy

Nagueh, S. F., Ommen, S. R., Lakkis, N. M., Killip, D., Zoghbi, W. A., Schaff, H. V., Danielson, G. K., Quiñones, M. A., Tajik, A. J., & Spencer, W. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01614-x · Cited by 240

Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic Stenosis

Harrison, D. C., D, E. B. M., Glick, G., Mason, D. T., Chidsey, C. A., & Ross, J. (1964) · Circulation · doi:10.1161/01.cir.29.1.84 · Cited by 239

Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study

Robinson, K., Frenneaux, M. P., Stockins, B., Karatasakis, G., Poloniecki, J. D., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80014-2 · Cited by 237

Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations

Binder, J. S., Ommen, S. R., Gersh, B. J., Driest, S. L. V., Tajik, A. J., Nishimura, R. A., & Ackerman, M. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.459 · Cited by 236

Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin t genes in hypertrophic cardiomyopathy

Ackerman, M. J., VanDriest, S. L., Ommen, S. R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01900-9 · Cited by 235

Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making

Grigg, L., Wigle, E. D., Williams, W. G., Daniel, L. B., & Rakowski, H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90135-a · Cited by 234

Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations

Maron, B. J., Niimura, H., Casey, S. A., Soper, M. K., Wright, G. B., Seidman, J. G., & Seidman, C. E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01386-9 · Cited by 234

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S. R., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214677 · Cited by 233

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.

Rosing, D. R., Kent, K. M., Borer, J. S., et al. (1979) · Circulation · doi:10.1161/01.cir.60.6.1201 · Cited by 232

Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy

Valeti, U. S., Nishimura, R. A., Holmes, D. R., Araoz, P. A., Glockner, J. F., Breen, J. F., Ommen, S. R., Gersh, B. J., Tajik, A. J., Rihal, C. S., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.055 · Cited by 231

Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae

Minakata, K., Dearani, J. A., Nishimura, R. A., Maron, B. J., & Danielson, G. K. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.09.040 · Cited by 230

Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy

Lakkis, N. M., Nagueh, S. F., Kleiman, N. S., Killip, D., He, Z., Verani, M. S., Roberts, R., & Spencer, W. H. (1998) · Circulation · doi:10.1161/01.cir.98.17.1750 · Cited by 230

Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy

McCully, R. B., Nishimura, R. A., Tajik, A. J., Schaff, H. V., & Danielson, G. K. (1996) · Circulation · doi:10.1161/01.cir.94.3.467 · Cited by 229

Muscular Subaortic Stenosis

Pollick, C. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210143071607 · Cited by 229

Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy

Yu, E., Omran, A., Wigle, E. D., Williams, W. G., Siu, S. C., & Rakowski, H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01019-6 · Cited by 226

Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy

Gietzen, F. H. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1520 · Cited by 223

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

McKenna, W. J., & Behr, E. R. (2002) · Heart · doi:10.1136/heart.87.2.169 · Cited by 222

To the Editor

Stöllberger, C., Pfersmann, V., & Finsterer, J. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.01.020 · Cited by 222

Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy

Robbins, R. C., & Stinson, E. B. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70310-0 · Cited by 219

Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs∗

D, E. B. M., & Ebert, P. A. (1962) · The American Journal of Cardiology · doi:10.1016/0002-9149(62)90373-9 · Cited by 217

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

Maki, S., Ikeda, H., Muro, A., Yoshida, N., Shibata, A., Koga, Y., & Imaizumi, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00455-x · Cited by 216

Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography

Kato, T. S., Noda, A., Izawa, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000150334.69355.00 · Cited by 216

Progress With Genetic Cardiomyopathies

Hershberger, R. E., Cowan, J. R., Morales, A., & Siegfried, J. D. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.817346 · Cited by 216

Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil

Bonow, R. O., Frederick, T. M., Bacharach, S. L., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90317-x · Cited by 216

Systolic Myocardial Mechanics in Hypertrophic Cardiomyopathy: Novel Concepts and Implications for Clinical Status

Carasso, S., Yang, H., Woo, A., Vannan, M. A., Jamorski, M., Wigle, E. D., & Rakowski, H. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.10.021 · Cited by 216

The case for surgery in obstructive hypertrophic cardiomyopathy

Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Gersh, B. J., & Nishimura, R. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.063 · Cited by 215

Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery11Supported, in part, by grant NCC9-60 from the National Aeronautics and Space Administration, Houston, Texas, Grant #9951522V from the America Heart Association Ohio Local Chapter, Columbus, Ohio and Grant #R01 HL56688-01A1 from the National Institutes of Health, Bethesda, Maryland.22Presented, in part, at the 49th Annual Scientific Sessions of American College of Cardiology, March 2000, Anaheim, California.

Xin, J., Shiota, T., Lever, H. M., Kapadia, S. R., Sitges, M., Rubin, D. N., Bauer, F., Greenberg, N. L., Agler, D. A., Drinko, J. K., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01656-4 · Cited by 211

Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy

ten Cate, F. J., Soliman, O. I. I., Michels, M., Theuns, D. A. M. J., de Jong, P. L., Geleijnse, M. L., & Serruys, P. W. J. C. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.862359 · Cited by 211

Recalls and Safety Alerts Involving Pacemakers and Implantable Cardioverter-Defibrillator Generators

Maisel, W. H. (2001) · JAMA · doi:10.1001/jama.286.7.793 · Cited by 210

Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy

Gimeno, J. R., Tome, M., Lofiego, C., Hurtado, J., Pantazis, A. A., Mist, B., Lambiase, P. D., McKenna, W. J., & Elliot, P. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp327 · Cited by 209

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.

Spirito, P., Rapezzi, C., Autore, C., Bruzzi, P., Bellone, P., Ortolani, P., Fragola, P. V., Chiarella, F., Zoni-Berisso, M., & Branzi, A. (1994) · Circulation · doi:10.1161/01.cir.90.6.2743 · Cited by 204

Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade

Cohen, L. S., & Braunwald, E. (1967) · Circulation · doi:10.1161/01.cir.35.5.847 · Cited by 204

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy

McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W.-K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203

Risk associated with pregnancy in hypertrophic cardiomyopathy

Autore, C., Conte, M. R., Piccininno, M., Bernabò, P., Bonfiglio, G., Bruzzi, P., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02495-6 · Cited by 199

Utility of continuous wave doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy

Panza, J. A., Petrone, R. K., Fananapazir, L., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90057-t · Cited by 199

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955

ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ

БАЗАРБАЕВА, Ә. А., Майгельдиева, Ш. М., & ЖҮНДІБАЕВА, Т. Н. (2023) · Pedagogy and Psychology · doi:10.51889/2077-6861.2023.1.30.016

चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )

Gaurav, S. K., & Swarnkar, P. (2017) · International research journal of multidisciplinary studies

FEATURES AND DIFFERENCES OF ADEQUATE AND EQUIVALENT TRANSLATION

Кенжебaевa, У., Nadirova, G. E., & Seitmetova, Z. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

Коммуникaтивно- прaгмaтический aнaлиз дипломaтических бумaг (нa основе вербaльных нот)

Кaмирдиновa, Н., & Кaлиевa, Ш. С. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141